UCB NORDIC A/S: Financial statements 2016
CVR: 26688949
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
UCB NORDIC A/S (CVR 26688949) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -35,467,000 and a net result of DKK 3,672,000 compared with DKK 2,102,000 the year before. Equity in the 2016 report amounted to DKK 10,375,000. The solvency ratio was 14.2%. The company had 25 employees in the financial year.
- Gross Profit
- DKK -35,467,000
- Profit/Loss
- DKK 3,672,000
- Equity
- DKK 10,375,000
- Total Assets
- DKK 73,309,000
- Employees
- 25
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -35.5 mio. | 3.7 mio. | 10.4 mio. | 25 |
| 2015 | - | 33.7 mio. | 2.1 mio. | 8.2 mio. | - |
| 2014 | - | 33.5 mio. | 2.7 mio. | 8.8 mio. | - |
| 2013 | - | 28.9 mio. | 403 t. | 6.5 mio. | 26 |
| 2012 | - | 31.4 mio. | -1.3 mio. | 6.1 mio. | 26 |
Official annual report
Find more companies like UCB NORDIC A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of December 1, 2016, Henrik Dramer Bøgebjerg Hansen is registered as director of UCB NORDIC A/S.
As of December 1, 2016, Arnaud Lefèvre has stepped down as adm. dir. of UCB NORDIC A/S.
UCB NORDIC A/S has published its annual report for 2015. Gross profit came to DKK 33,732,000, and the net result was DKK 2,102,000.
As of May 2, 2016, Arnaud Lefèvre has joined the board of directors of UCB NORDIC A/S.
As of May 2, 2016, Flemming Erik Allan Andersen has left the board of directors of UCB NORDIC A/S.
As of May 2, 2016, Arnaud Lefèvre is registered as adm. dir. of UCB NORDIC A/S.
As of May 2, 2016, Flemming Erik Allan Andersen has stepped down as adm. dir. of UCB NORDIC A/S.
As of February 4, 2016, Willy Constant Cnops has joined the board of directors of UCB NORDIC A/S.
About UCB NORDIC A/S
UCB NORDIC A/S is a Danish company of the type Aktieselskab based in København S, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named UCB NORDICS ApS and CELLTECH NORDIC ApS. The management consists of Mari-Ann Retz. The board consists of Laura Ann Byram (chair), Christina Dyreborg Jeppesen and Jaana Mattila. The company is owned by UCB Pharma SA. The company has 48 employees (2026). In 2025, the company reported a gross profit of DKK 88,278,000 and a net result of DKK 6,014,000 compared with DKK 5,226,000 the year before. Equity in the 2025 report amounted to DKK 18,047,000.